Alamar Biosciences, Inc. Share-based Payment Arrangement, Expense
Alamar Biosciences, Inc. (ALMR) reported Share-based Payment Arrangement, Expense of $3.28 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-11
- Alamar Biosciences, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $3.28M, a 382.35% increase year-over-year.
- Alamar Biosciences, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $1.47M, a 137.00% increase year-over-year.
- Alamar Biosciences, Inc. share-based payment arrangement, expense for the quarter ending 2025-06-30 was $680.00K.
- Alamar Biosciences, Inc. share-based payment arrangement, expense for the quarter ending 2025-03-31 was $619.00K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month |
|---|---|---|
| 2026-06-30 | $3.28M 10-Q · filed 2026-08-11 | $4.75M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $1.47M 10-Q · filed 2026-05-08 | |
| 2025-06-30 | $680.00K 10-Q · filed 2026-08-11 | $1.30M 10-Q · filed 2026-08-11 |
| 2025-03-31 | $619.00K 10-Q · filed 2026-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |